Dr. Craig Devoe, lead investigator of clinical trial at Northwell Health, answers your questions on the plasma study
Dr. Craig Devoe spoke to News 12's Elizabeth Hashagen today. Dr. Devoe is the lead investigator of a clinical trial at Northwell Health studying blood from survivors as a possible treatment for COVID-19.
•
Apr 13, 2020, 2:09 PM
•
Updated 1,713 days ago
Share:
Dr. Craig Devoe spoke to News 12's Elizabeth Hashagen today. Dr. Devoe is the lead investigator of a clinical trial at Northwell Health studying blood from survivors as a possible treatment for COVID-19.
This is what he says are the prerequisites for survivors to donate blood and possibly be a part of the study:
- You need to be without symptoms for 14 days;
- You have to have had a positive test showing that you had COVID-19.
More from News 12
NYPD Chief of Department Jeffrey Maddrey resigns
1:37
STORM WATCH: Morning snow followed by deep cold in Brooklyn
0:32
NYPD: Man’s face slashed at Dumbo subway station; suspect sought
1:28
FDA announces new criteria for what foods can be considered healthy
1:56
Thunderbolt 12: Checking road conditions in Borough Park
